Joshua T. Elliott

Mr. Elliott's practice focuses on patent law matters related to biochemistry and biotechnology, including counseling clients on complex patent law issues such as freedom-to-operate, infringement, validity and design around strategies. His practice also includes rendering opinions, conducting patent due diligence investigations, advising clients on patent portfolio strategies and preparing and prosecuting patent applications. Josh has assisted clients with a variety of technologies in areas such as proteins, peptides, nucleic acids, antibodies, cell-based assays, pharmaceuticals, proteomics, metabolomics, RNA interference and vaccines.

Josh has particular experience in advising biopharmaceutical companies and generic pharmaceutical companies on patent issues related to advancing products to market.

• University of Dayton School of Law
  Loren M. Berry Scholarship (full merit scholarship)
  University of Dayton Law Review, 1997-1999
• University of North Carolina at Chapel Hill
  Phi Beta Kappa

• "Confronting the Written Description Requirement Post-Centocor and Evaluating its Impact on Biotech Patent Practices," ACI’s Conference on Biotech Patents, Boston, Mass., December 1, 2011

• North Carolina Bar Association
  Co-chair, Chemical and Biotechnology Patents Committee, 2007-present
• American Intellectual Property Law Association

• Brinks Celebrates Opening of Research Triangle Park Office
• Brinks Hofer Gilson & Lione Expands to High-Tech Research Triangle Park Area; Adds Accomplished Patent Attorneys to Its New Office

• Triangle Business Leader
• Triangle Business Leader
• Various Media
• Various Media